The growing debate over spine surgery’s safety net

Advertisement

In spine surgery, the cost of an extra safeguard can be measured in dollars. The cost of going without one can be measured in a patient’s ability to walk.

That tension sits at the center of a debate Gbolabo Sokunbi, MD, believes the specialty has yet to resolve: When does an additional layer of protection become an unnecessary expense, and who gets to decide?

Dr. Sokunbi, a spine surgeon at New York City-based Hospital for Special Surgery and assistant professor of orthopedic surgery at Weill Cornell Medical College, also in New York City, has seen the benefits of intraoperative neuromonitoring firsthand. The technology tracks neurological signals during surgery, helping teams identify potential nerve or spinal cord injuries.

But he also sees a growing disconnect between how widely the technology is used and how clearly its value has been established across different procedures.

“Not everyone necessarily needs the technology,” he told Becker’s. For Dr. Sokunbi, the challenge is developing a more precise understanding of where safety and cost intersect.

When protection becomes precaution

Intraoperative neuromonitoring was historically associated with major scoliosis and spinal deformity corrections. Its use has since expanded to a broader range of procedures, including operations involving trauma, tumors and spinal cord compression.

Dr. Sokunbi considers the technology particularly valuable in complex cases in which neurological structures are at greater risk.

Sometimes, its greatest benefit has little to do with the operation itself. During lengthy spinal reconstructions, monitoring can detect abnormal signals in a patient’s arm even when the surgeon is operating on the lower back. Such changes may alert the team to a positioning problem before an unrelated injury develops.

But the rationale becomes less clear in lower-risk procedures, such as certain single-level lumbar decompressions. In New York City, Dr. Sokunbi said, medicolegal concerns can influence whether surgeons use monitoring, even when its necessity is uncertain.

“If you practice in a highly litigious environment, sometimes you’re kind of forced to use the technology because you don’t want to be subject to a lawsuit where a neurological injury occurred,” he said.

That concern can create a difficult calculation. Neuromonitoring adds expense and cannot detect every injury, yet even a single preventable neurological complication can have devastating consequences. As Dr. Sokunbi put it, “One injury may be too many.”

What the evidence still cannot answer

Research in which Dr. Sokunbi has been involved has raised questions about routine neuromonitoring in lower-risk lumbar procedures. 

In a study of 401 patients undergoing posterior lumbar interbody fusion, researchers found that certain changes in somatosensory evoked potentials were associated with postoperative motor deficits, but the monitoring method had limited sensitivity and predictive value. Electromyography changes were not significantly associated with those deficits.

The findings, published in Global Spine Journal, suggested that monitoring should be tailored to individual surgical risks rather than used routinely in every comparable case.

For Dr. Sokunbi, the uncertainty extends beyond patient selection. At HSS, he said, a neurologist remotely interprets neuromonitoring signals in real time, alongside assessments by the surgeon and anesthesia team.

That additional oversight helps the team evaluate complex signal changes without placing the entire burden of interpretation on the operating surgeon.

But not every hospital uses identical staffing arrangements or protocols. Dr. Sokunbi said he believes the specialty needs greater consistency in both how monitoring is interpreted and which patients receive it. Without shared standards, practices can vary according to institutional resources, geography and individual surgeon preferences.

Who should set the rules?

As hospitals face mounting pressure to justify technology spending, Dr. Sokunbi argues that decisions about neuromonitoring should remain grounded in clinical judgment.

“It shouldn’t be driven by administration or C-suite people,” he said. “It really should be a clinical discussion.”

He believes surgeons should establish clearer, risk-based recommendations that account for factors such as spinal instrumentation, cervical or thoracic cord involvement and complex traumatic injuries.

Reaching that consensus will require closer collaboration between orthopedic spine surgeons and neurosurgeons, who often train and participate in professional organizations separately.

For Dr. Sokunbi, developing shared guidelines would help reduce the influence of local practice patterns and create a more consistent framework for determining when monitoring adds meaningful protection.

It could also give hospitals a stronger clinical basis for evaluating its cost.

The next frontier: Smarter, not more

Dr. Sokunbi believes AI could eventually help resolve some of the uncertainty. Predictive analytics may make it possible to identify patients at greatest risk of neurological complications, allowing monitoring resources to be concentrated where they are most likely to make a difference.

AI could also help interpret complex signals more efficiently, potentially reducing some of the personnel costs associated with the technology.

Those applications remain possibilities rather than established replacements for current monitoring practices.

But they reflect a principle Dr. Sokunbi believes should guide spine surgery innovation more broadly: New technology should strengthen sound clinical decision-making, not substitute for it. He sees the same risk with other surgical advances, including expandable cages, when surgeons expect a device to accomplish work that still depends on proper technique.

“If you’re just using it to use it, you’re not going to have an acceptable outcome,” he said.

For Dr. Sokunbi, the next advance in neuromonitoring may not be a more sophisticated system or another layer of surveillance. It may be the evidence and clinical consensus needed to determine exactly when that protection matters most.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spine

Advertisement